Clinical Study Results
What adverse reactions did the participants have?
The only adverse reaction that happened during the study was headache. This
adverse reaction happened in:
• 16.7% of participants who took 50 mg of AZD9977. This was 1 out of 6
participants.
• 22.2% of participants who took the placebo. This was 2 out of 9 participants.
How has this study helped patients and
researchers?
This study helped researchers learn more about the safety of AZD9977 in healthy
participants.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Other clinical studies with AZD9977 are planned.
7